ZA952121B - Skin treatment composition - Google Patents

Skin treatment composition

Info

Publication number
ZA952121B
ZA952121B ZA952121A ZA952121A ZA952121B ZA 952121 B ZA952121 B ZA 952121B ZA 952121 A ZA952121 A ZA 952121A ZA 952121 A ZA952121 A ZA 952121A ZA 952121 B ZA952121 B ZA 952121B
Authority
ZA
South Africa
Prior art keywords
treatment composition
skin treatment
skin
composition
treatment
Prior art date
Application number
ZA952121A
Other languages
English (en)
Inventor
Alan Evenson
Walter Thomas Gibson
Martin Richard Green
Robert Guy
Terence George Evelyn Kealey
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of ZA952121B publication Critical patent/ZA952121B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA952121A 1994-03-15 1995-03-15 Skin treatment composition ZA952121B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9405021A GB9405021D0 (en) 1994-03-15 1994-03-15 Skin treatment composition

Publications (1)

Publication Number Publication Date
ZA952121B true ZA952121B (en) 1996-09-16

Family

ID=10751870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952121A ZA952121B (en) 1994-03-15 1995-03-15 Skin treatment composition

Country Status (9)

Country Link
EP (1) EP0750510B1 (fr)
JP (1) JPH09510443A (fr)
AU (1) AU2068295A (fr)
CA (1) CA2181162A1 (fr)
DE (1) DE69528637T2 (fr)
ES (1) ES2185698T3 (fr)
GB (1) GB9405021D0 (fr)
WO (1) WO1995024917A1 (fr)
ZA (1) ZA952121B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
WO1999037321A1 (fr) * 1998-01-22 1999-07-29 Gosudarstvenny Nauchno-Issledovatelsky Institut Osobo Chistykh Biopreparatov (Gosnii Ochb) Preparation immuno-modulatrice a base d'interleukine 1 et procede de preparation
AU713873B3 (en) * 1999-08-02 1999-12-09 Stephen Pemberton Dispenser system
CN107596365A (zh) 2010-06-18 2018-01-19 埃克斯生物科技公司 关节炎治疗
KR20160062200A (ko) 2010-08-23 2016-06-01 엑스바이오테크, 인크. 종양성 질병들에 대한 치료
US9724409B2 (en) 2011-04-01 2017-08-08 Xbiotech, Inc. Treatment of inflammatory skin disease
KR20190090046A (ko) * 2011-04-01 2019-07-31 엑스바이오테크, 인크. 피부과학적 병리의 치료
KR20150064091A (ko) * 2012-10-04 2015-06-10 엑스바이오테크, 인크. 정신의학적 병태의 치료법
KR20190117579A (ko) 2017-02-16 2019-10-16 엑스바이오테크, 인크. 화농성 한선염의 치료

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005653A1 (fr) * 1987-12-18 1989-06-29 Immunex Corporation Preparations de traitement topique de blessures contenant des proteines interleucines-1
IL105741A0 (en) * 1992-05-22 1993-09-22 Genta Inc Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds

Also Published As

Publication number Publication date
WO1995024917A1 (fr) 1995-09-21
EP0750510A1 (fr) 1997-01-02
DE69528637D1 (de) 2002-11-28
JPH09510443A (ja) 1997-10-21
AU2068295A (en) 1995-10-03
DE69528637T2 (de) 2003-06-26
ES2185698T3 (es) 2003-05-01
GB9405021D0 (en) 1994-04-27
EP0750510B1 (fr) 2002-10-23
CA2181162A1 (fr) 1995-09-21

Similar Documents

Publication Publication Date Title
ZA96740B (en) Skin treatment composition
ZA953256B (en) Skin treatment composition
GB9507130D0 (en) Hair treatment composition
GB9411080D0 (en) Treatment
IL109012A0 (en) Skin whitening composition
GB9622659D0 (en) Hair treatment composition
EP0815838A3 (fr) Préparation par les soins de la peau à l'application externe
GB9803642D0 (en) Hair treatment composition
EP0612513A3 (en) External skin treatment composition.
ZA951510B (en) Skin cleansing composition
GB9423974D0 (en) Skin care compositions
GB9410512D0 (en) Novel treatment
ZA952121B (en) Skin treatment composition
EP0845975A4 (fr) Compose pour le traitement des cheveux
GB9411635D0 (en) Novel treatment
GB9405046D0 (en) Skin treatment composition
GB9415901D0 (en) Novel compounds and treatment
ZA953237B (en) Medical treatment
GB9415900D0 (en) Novel compounds and treatment
EP0797592A4 (fr) Stanniocalcine-alpha humaine
GB9620085D0 (en) Cosmetic treatment
ZA947865B (en) Human glactokinase
GB9507482D0 (en) Skin treatment composition
EP0795006A4 (fr) MutT2 HUMAIN
GB9425112D0 (en) Hair treatment